A new measure of predictive ability for survival models

por Choodari-Oskooei, Babak, Royston, Patrick, Parmar, Mahesh KB
Publicado 2011

Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework

por Blenkinsop, Alexandra, Parmar, Mahesh KB, Choodari-Oskooei, Babak
Publicado 2019

The extension of total gain (TG) statistic in survival models: properties and applications

por Choodari-Oskooei, Babak, Royston, Patrick, Parmar, Mahesh K.B.
Publicado 2015

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome

por Choodari-Oskooei, Babak, Parmar, Mahesh KB, Royston, Patrick, Bowden, Jack
Publicado 2013

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome

por Choodari-Oskooei, Babak, Parmar, Max KB, Royston, Patrick, Bowden, Jack
Publicado 2013

Review and evaluation of performance measures for survival prediction models in external validation settings

por Rahman, M. Shafiqur, Ambler, Gareth, Choodari-Oskooei, Babak, Omar, Rumana Z.
Publicado 2017

Combined test versus logrank/Cox test in 50 randomised trials

por Royston, Patrick, Choodari-Oskooei, Babak, Parmar, Mahesh K. B., Rogers, Jennifer K.
Publicado 2019

Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit

por Royston, Patrick, Barthel, Friederike M-S, Parmar, Mahesh KB, Choodari-Oskooei, Babak, Isham, Valerie
Publicado 2011

Point estimation for adaptive trial designs I: A methodological review

por Robertson, David S., Choodari‐Oskooei, Babak, Dimairo, Munya, Flight, Laura, Pallmann, Philip, Jaki, Thomas
Publicado 2022

Point estimation for adaptive trial designs II: practical considerations and guidance

por Robertson, David S., Choodari-Oskooei, Babak, Dimairo, Munya, Flight, Laura, Pallmann, Philip, Jaki, Thomas
Publicado 2023

Measuring the impact of methodological research: a framework and methods to identify evidence of impact

por Brueton, Valerie C, Vale, Claire L, Choodari-Oskooei, Babak, Jinks, Rachel, Tierney, Jayne F
Publicado 2014

Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes

por Bratton, Daniel J., Parmar, Mahesh K. B., Phillips, Patrick P. J., Choodari-Oskooei, Babak
Publicado 2016

Treatment selection in multi-arm multi-stage designs: With application to a postpartum haemorrhage trial

por Choodari-Oskooei, Babak, Thwin, Soe Soe, Blenkinsop, Alexandra, Widmer, Mariana, Althabe, Fernando, Parmar, Mahesh KB
Publicado 2023

Proposals on Kaplan–Meier plots in medical research and a survey of stakeholder views: KMunicate

por Morris, Tim P, Jarvis, Christopher I, Cragg, William, Phillips, Patrick P J, Choodari-Oskooei, Babak, Sydes, Matthew R
Publicado 2019

Adding new experimental arms to randomised clinical trials: Impact on error rates

por Choodari-Oskooei, Babak, Bratton, Daniel J, Gannon, Melissa R, Meade, Angela M, Sydes, Matthew R, Parmar, Mahesh KB
Publicado 2020

Combining factorial and multi-arm multi-stage platform designs to evaluate multiple interventions efficiently

por White, Ian R, Choodari-Oskooei, Babak, Sydes, Matthew R, Kahan, Brennan C, McCabe, Leanne, Turkova, Anna, Esmail, Hanif, Gibb, Diana M, Ford, Deborah
Publicado 2022

Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Research Partn...

por Law, Martin, Couturier, Dominique-Laurent, Choodari-Oskooei, Babak, Crout, Phillip, Gamble, Carrol, Jacko, Peter, Pallmann, Philip, Pilling, Mark, Robertson, David S., Robling, Michael, Sydes, Matthew R., Villar, Sofía S., Wason, James, Wheeler, Graham, Williamson, S. Faye, Yap, Christina, Jaki, Thomas
Publicado 2023

Correction: Medicines and Healthcare products Regulatory Agency’s “Consultation on proposals for legislative changes for clinical trials”: a response from the Trials Methodology Re...

por Law, Martin, Couturier, Dominique-Laurent, Choodari-Oskooei, Babak, Crout, Phillip, Gamble, Carrol, Jacko, Peter, Pallmann, Philip, Pilling, Mark, Robertson, David S., Robling, Michael, Sydes, Matthew R., Villar, Sofía S., Wason, James, Wheeler, Graham, Williamson, S. Faye, Yap, Christina, Jaki, Thomas
Publicado 2023

Adaptive designs in clinical trials: why use them, and how to run and report them

por Pallmann, Philip, Bedding, Alun W., Choodari-Oskooei, Babak, Dimairo, Munyaradzi, Flight, Laura, Hampson, Lisa V., Holmes, Jane, Mander, Adrian P., Odondi, Lang’o, Sydes, Matthew R., Villar, Sofía S., Wason, James M. S., Weir, Christopher J., Wheeler, Graham M., Yap, Christina, Jaki, Thomas
Publicado 2018

RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of rela...

por Oza, Bhavna, Frangou, Eleni, Smith, Ben, Bryant, Hanna, Kaplan, Rick, Choodari-Oskooei, Babak, Powles, Tom, Stewart, Grant D., Albiges, Laurence, Bex, Axel, Choueiri, Toni K., Davis, Ian D., Eisen, Tim, Fielding, Alison, Harrison, David, McWhirter, Anita, Mulhere, Salena, Nathan, Paul, Rini, Brian, Ritchie, Alastair, Scovell, Sarah, Shakeshaft, Clare, Stockler, Martin R., Thorogood, Nat, Parmar, Mahesh K.B., Larkin, James, Meade, Angela
Publicado 2021